comparemela.com

Latest Breaking News On - Raches ella - Page 8 : comparemela.com

Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine

Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine Firstpost 5 days ago © Provided by Firstpost Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine Bharat Biotech International Limited (BBIL) has applied to the World Health Organisation (WHO) to get an emergency use listing (EUL) for its COVID-19 vaccine. It hopes to get the nod by the third or fourth quarter of this year. BBIL has submitted 90 percent of required documents to WHO to get approval, and the remaining documents will be submitted by June, the Hyderabad-based pharma company told the Central government during a discussion. The meeting was attended by the company s managing director V Krishna Mohan and his colleagues, along with senior officers of the Ministry of Health, Department of Biotechnology and Ministry of External Affairs and Foreign Secretary Harsh Vardhan Shringla. Speaking to 

Regulatory approvals for COVAXIN is in process in more than 60 countries: Bharat Biotech

Regulatory approvals for COVAXIN is in process in more than 60 countries: Bharat Biotech Hyderabad, May 25 (UNI) Regulatory approvals for indigenously developed Covid-19 vaccine ‘Covaxin’ are in process in more than 60 countries including USA, Brazil and Hungary, according to Hyderabad-based global vaccine maker Bharat Biotech here on Tuesday. Emergency use authorisations (EUA) have been obtained from 13 countries with more to follow. Bharat Biotech has submitted an application to the World Health Organisation (WHO ) for EUL (Emergency Use Listing) for indigenously developed Covid-19 vaccine ‘Covaxin ‘ and regulatory approvals are expected by Jul-Sept 2021. Most countries recommend vaccinations against COVID-19. Unvaccinated travelers can travel with negative RT-PCR tests prior to travel, in the absence of any other country specific travel restrictions.

Regulatory approvals for COVAXIN is in process in more than 60 countries: Bharat Biotech

Regulatory approvals for COVAXIN is in process in more than 60 countries: Bharat Biotech
uniindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uniindia.com Daily Mail and Mail on Sunday newspapers.

Paediatric trials of Covaxin may begin in June

Paediatric trials of Covaxin may begin in June ANI | Updated: May 24, 2021 03:06 IST Hyderabad (Telangana) [India], May 24 (ANI): Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company s Business Development and International Advocacy Head Dr Raches Ella on Sunday. Holding a virtual conversation with members of FICCI Ladies Organisation (FLO) Hyderabad on All About Vaccines, he said that the company expected approval from the World Health Organisation (WHO) for Covaxin by the end of the third or fourth quarter. I am happy that our hard work is paying off well as the vaccine is working well and saving lives. We have this good feeling when we go back home from work each day. We will be soon ramping up our manufacturing capacity to 700 million doses by the end of this year, informed Dr. Raches Ella as a response to a question from a participant.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.